Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TranscatTRNS +0.88%93 EBITDA Margin % is 11.47% as of Jun. 2026, which is 3% above its 10-year median of 11.13. GuruFocus rates TRNS with a GF Score™ of 93/100 and a GF Value™ of $107.99 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 1,069 Business Services companies, Transcat ranks better than 51.08% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Transcat's EBITDA for the
three
months ended in Jun. 2026 was $10.7 Mil. Transcat's Revenue for the
three
months ended in Jun. 2026 was $92.9 Mil. Therefore, Transcat's EBITDA margin for the quarter that ended in Jun. 2026 was 11.47%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Transcat EBITDA Margin % Related Terms
Transcat EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Transcat's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TRNS vs BKSY, KODK, CASS: EBITDA Margin % Comparison
For the Specialty Business Services subindustry, Transcat's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Transcat EBITDA Margin % vs Business Services Industry
For the Business Services industry and Industrials sector, Transcat's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Transcat's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Transcat (TRNS) has a EBITDA Margin % of 11.47% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Transcat and its competitors. This is near median its historical median of 11.13. Over the past decade, Transcat's EBITDA Margin % has ranged from 9.68 to 13.54. According to the industry distribution chart, Transcat ranks #523 out of 1069 companies in the Business Services industry, placing it in the top 48.9%.
Is Transcat's EBITDA Margin % too high?
Transcat's current EBITDA Margin % of 11.47% is near median its 10-year median of 11.13. Over the past 10 years, this metric has ranged from a low of 9.68 to a high of 13.54. The Business Services industry median EBITDA Margin % is 10.91. Transcat's value of 11.47% is 5.1% above this industry median. Based on the distribution chart, Transcat ranks #523 out of 1069 companies in the Business Services industry, which is above the industry midpoint. Overall, Transcat has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Transcat's EBITDA Margin % compare to BKSY and KODK?
According to the Business Services industry distribution chart, Transcat ranks #523 out of 1069 companies for EBITDA Margin %. This puts Transcat in the upper half of its industry. The industry median EBITDA Margin % is 10.91. Transcat's value of 11.47% is 5.1% above this benchmark. Historically, Transcat's own EBITDA Margin % has ranged from 9.68 to 13.54 over the past decade. While the company's 10-year median is 11.13 vs. the industry median of 10.91, Transcat has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Business Services company?
The median EBITDA Margin % among Business Services companies is 10.91, based on 1,069 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Transcat's current EBITDA Margin % of 11.47% is 5.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Transcat and its competitors. For the Business Services industry, the median EBITDA Margin % is 10.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Transcat's current EBITDA Margin % is 11.47%, which is near median its own 10-year median of 11.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Transcat stock overvalued right now?
Based on GuruFocus' analysis, Transcat (TRNS) is currently considered Modestly Undervalued. The stock's GF Value™ is $107.99, compared to a current price of $91.98 — trading 14.8% below its estimated fair value. The current EBITDA Margin % is 11.47%, which is near median its 10-year median of 11.13 and 5.1% above the Business Services industry median of 10.91. Transcat's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Transcat (TRNS), the current EBITDA Margin % is 11.47% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Transcat (TRNS) Overvalued in 2026?
Based on GuruFocus' analysis, Transcat stock appears to be undervalued.
The current stock price of $91.98 is trading 14.8% below its estimated GF Value™ of $107.99.
GuruFocus considers Transcat to be Modestly Undervalued.
Key valuation signals for TRNS:
EBITDA Margin %: 11.47% (near median its 10-year median of 11.13)
GF Value™: $107.99 vs. price of $91.98 (14.8% below fair value)
Industry Position: 5.1% above the Business Services median (#523 of 1069)
No single metric tells the full story. See the TRNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
93GF Score
Get the complete analysis for TRNS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TRNS has been successfully added to your 
